$4.600
-0.459 (-9.98%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
TNXP Prediction & Forecast by Similar Chart Analysis
Alphio's TNXP stock price prediction model matches the current Tonix Pharmaceuticals Holding Corp tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $4.54 (-1.41%). The 1-week path is $4.50 (-2.13%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Tonix Pharmaceuticals Holding Corp Stock?
Tonix Pharmaceuticals appears to be a good buy right now due to its current price of $5.15, significantly below its 52-week high of $20.56, indicating potential for recovery. The company has shown strong revenue growth, with Q2 2026 net product revenue reaching $13.54 million, up from $2 million year-over-year. Additionally, the gross margin has improved to 94.81% in Q2 2026, reflecting operational efficiency. However, the main risk is the high net loss of $40.6 million in Q2 2026, which could impact future performance if not managed effectively.
TNXP stock price ended at $4.60 on Thursday, after losing -9.98%
Tonix Pharmaceuticals Holding Corp (TNXP) last closed at $4.5999999, losing -9.98%. These facts feed the 1-day and 1-week TNXP price prediction above.
Analyst Consensus
Tonix Pharmaceuticals Holding Corp (TNXP): 3 buy, 0 hold, 0 sell. Outlook: Strong Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Forecast Drivers
Tonix Pharmaceuticals Holding Corp (TNXP) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches TNXP, ranked by similarity.
Seasonality analysis for TNXP
Historically the probability of a positive November return for TNXP is 0.00%. June offers the highest probability of a positive month at 33.33%, while March is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for TNXP
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Nov 2026 | $37.47 | $42.55 | $47.57 | +824.91% |
| Dec 2026 | $41.35 | $45.49 | $47.56 | +888.97% |
In 2026, Tonix Pharmaceuticals Holding Corp (TNXP) is projected to range from $37.47 to $47.57.
Tonix Pharmaceuticals Holding Corp 2026 monthly forecast
In Nov 2026, Tonix Pharmaceuticals Holding Corp is projected to average $42.55, with a low of $37.47 and high of $47.57.
In Dec 2026, Tonix Pharmaceuticals Holding Corp is projected to average $45.49, with a low of $41.35 and high of $47.56.
Related articles
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.